Ezicef-S 750

zicef-S 750 Injection: Composition and Benefits

Composition (per vial):

• Ceftriaxone 500 mg: A third-generation cephalosporin antibiotic that targets a wide variety of bacterial infections, disrupting bacterial cell wall synthesis.
• Sulbactam 250 mg: A beta-lactamase inhibitor that enhances the effectiveness of Ceftriaxone by protecting it from bacterial enzymes that would otherwise degrade the antibiotic.

Pack Size:
Available as a 750 mg injection (Ceftriaxone 500 mg + Sulbactam 250 mg per vial).

Benefits of Ezicef-S 750 Injection:

Ezicef-S 750 Injection provides effective treatment for a variety of bacterial infections by combining Ceftriaxone with Sulbactam.

• Broad-Spectrum Antibiotic: Effective against many types of bacterial infections, including those caused by resistant strains.
• Enhanced Efficacy: The addition of Sulbactam ensures that Ceftriaxone remains effective against bacteria that produce beta-lactamase, an enzyme that can otherwise break down many antibiotics.
• Treatment for Severe Infections: Ideal for serious infections like pneumonia, intra-abdominal infections, and urinary tract infections, often in hospital settings.

Ezicef-S 750 Injection is used for treating severe and resistant bacterial infections in patients who require intravenous therapy.

Usage Instructions:

Administer Ezicef-S 750 Injection as prescribed by your healthcare provider. The injection is typically given intravenously or intramuscularly, depending on the infection type and severity.